Skip to content
lifestyle.celebhomes.net
Home
Sample Page
Author:
AbelZeta Pharma, Inc
AbelZeta Announces Remaining China Rights to GPC3 Armored CAR-T Therapy to be Acquired by AstraZeneca
January 23, 2026
ElpasBio and Fosun Kairos Announce Commercialization Collaboration for AlloJoin® Stem Cell Therapy
January 14, 2026
AbelZeta to Attend 44th Annual J.P. Morgan Healthcare Conference and Join Panel Discussion
January 6, 2026